ChildStats.gov—Forum on Child and Family Statistics
faces of children
Home  |  About the Forum  |  Publications  |  Data Sources  |  Help
Search
HC3.B Immunization: Percentage of adolescents ages 13–17 years vaccinated for selected diseases by poverty statusa and race and Hispanic origin,b 2006–2011

excel icon HC3B Excel Table

  Total Below 100% poverty 100% poverty and above
Characteristic 2006c 2007c 2008 2009 2010 2011 2006c 2007c 2008 2009 2010 2011 2006c 2007c 2008 2009 2010 2011
Total
MMR (2 doses or more)d 86.9 88.9 89.3 89.1 90.5 91.1 87.1 87.8 87.8 90.3 89.6 89.3 91.1 91.4
HepB (3 doses or more)e 81.3 87.6 87.9 89.9 91.6 92.3 86.7 88.3 89.0 91.4 88.0 90.3 92.4 92.6
Var (1 dose or more)f 65.5 75.7 81.9 87.0 90.5 92.3 77.0 82.9 86.7 91.1 82.9 87.6 91.2 92.6
Var (2 doses or more)g 34.1 48.6 58.1 68.3 35.8 46.2 53.8 67.2 33.9 48.7 58.9 68.4
Td or Tdap (1 dose or more)h 60.1 72.3 72.2 76.2 81.2 85.3 70.9 71.8 76.8 81.5 72.7 77.0 82.2 86.5
Tdap (1 dose or more)i 10.8 30.4 40.8 55.6 68.7 78.2 38.6 52.8 64.7 74.0 41.2 56.1 69.5 79.5
MenACWY (1 dose or more)j 11.7 32.4 41.8 53.6 62.7 70.5 40.8 52.5 62.0 69.0 42.0 63.8 62.9 70.7
HPV (1 dose or more)—females onlyk 25.1 37.2 44.3 48.7 53.0 46.4 51.9 51.8 62.1 35.8 42.5 47.7 50.1
HPV (3 doses or more)—females onlyl 17.9 26.7 32.0 34.8 14.9 25.5 28.2 39.0 18.6 26.8 32.9 33.4
White, non-Hispanic
MMR (2 doses or more)d 89.9 90.2 91.6 91.4 89.2 86.7 90.4 88.5 89.7 90.4 91.7 91.9
HepB (3 doses or more)e 88.1 90.2 92.7 92.8 88.4 87.4 90.8 90.7 87.9 90.5 92.8 93.1
Var (1 dose or more)f 82.8 88.5 91.2 92.9 74.4 79.3 85.6 91.2 82.9 88.9 91.7 93.2
Var (2 doses or more)g 31.6 48.8 59.2 67.3 34.2 42.9 60.8 49.1 60.4 68.1
Td or Tdap (1 dose or more)h 71.6 76.5 80.9 85.1 64.5 68.6 70.2 77.5 72.3 77.1 82.1 86.2
Tdap (1 dose or more)i 41.7 55.8 68.6 78.6 32.8 49.5 57.5 70.7 42.5 56.1 69.9 79.6
MenACWY (1 dose or more)j 39.7 53.1 61.2 68.4 32.8 47.1 50.3 58.5 48.9 53.3 62.5 69.7
HPV (1 dose or more)—females onlyk 35.0 43.9 45.8 47.5 37.3 52.5 39.4 53.6 35.7 43.0 46.6 46.7
HPV (3 doses or more)—females onlyl 19.5 29.1 32.4 33.0 25.7 32.5 32.8 33.0
Black, non-Hispanic
MMR (2 doses or more)d 89.1 86.3 90.8 90.6 89.1 84.4 92.1 90.7 88.6 86.9 90.2 90.8
HepB (3 doses or more)e 86.0 88.9 90.9 91.7 86.9 86.6 90.0 91.3 85.8 89.8 91.3 92.3
Var (1 dose or more)f 74.0 82.4 89.2 91.3 72.7 79.8 87.0 91.1 74.8 82.8 89.5 91.2
Var (2 doses or more)g 35.0 43.9 55.3 65.3 44.4 60.3 64.7 44.2 51.8 65.3
Td or Tdap (1 dose or more)h 71.4 72.5 80.5 83.1 68.9 69.5 80.1 79.1 71.9 74.8 80.1 85.4
Tdap (1 dose or more)i 36.0 52.7 66.9 75.7 39.0 47.7 68.1 72.1 33.4 55.6 66.0 77.7
MenACWY (1 dose or more)j 43.1 53.0 63.4 72.1 38.8 52.0 66.5 72.0 40.3 53.8 61.4 71.5
HPV (1 dose or more)—females onlyk 35.7 44.6 48.9 56.0 53.0 51.6 55.7 60.2 31.2 40.7 44.5 52.5
HPV (3 doses or more)—females onlyl 14.9 23.1 30.2 31.7 31.6 36.6 28.6 28.0
Hispanic
MMR (2 doses or more)d 87.5 87.6 86.2 90.6 83.9 90.6 83.5 91.7 90.4 85.4 88.1 89.4
HepB (3 doses or more)e 89.8 90.0 88.9 91.7 86.2 90.3 87.8 93.0 92.1 89.8 91.0 90.7
Var (1 dose or more)f 84.5 85.5 90.6 91.0 80.0 84.6 88.1 92.5 88.9 85.6 92.1 89.6
Var (2 doses or more)g 38.5 49.7 56.2 71.4 49.7 55.8 73.8 49.4 56.7 69.4
Td or Tdap (1 dose or more)h 74.1 76.7 82.4 86.7 74.8 74.2 78.9 85.0 75.7 77.4 85.0 88.3
Tdap (1 dose or more)i 41.9 55.6 69.6 78.4 40.4 55.8 67.4 76.1 44.0 54.8 70.6 80.6
MenACWY (1 dose or more)j 46.8 55.9 66.1 75.3 45.0 56.2 67.4 77.2 44.7 55.9 64.4 73.6
HPV (1 dose or more)—females onlyk 44.4 45.5 56.2 65.0 45.9 52.2 57.9 69.2 39.3 42.0 53.5 61.9
HPV (3 doses or more)—females onlyl 14.7 23.4 29.5 41.6 27.1 44.9 32.9 39.5
— Not available.
a Based on family income and household size using Census Bureau poverty thresholds for the year of data collection.
b The revised 1997 Office of Management and Budget (OMB) standards for data on race and ethnicity were used. Persons could select one or more from the following racial groups: White, Black or African American, American Indian or Alaska Native, Asian, or Native Hawaiian or Other Pacific Islander. Persons of Hispanic origin may be of any race. Included in the total but not shown separately are American Indian or Alaska Native, Asian, Native Hawaiian or Other Pacific Islander and "Two or more races" due to the small sample size. Data on race and Hispanic origin are collected separately but combined for reporting.
c Data collection for 2006 and 2007 was only performed during the fourth quarter of each year.
d Includes 2 doses (or more) of measles-mumps-rubella vaccine received at any age.
e Includes 3 doses (or more) of hepatitis B vaccine received at any age.
f Includes 1 dose (or more) of varicella vaccine received at any age and without a history of varicella disease.
g Includes 2 doses (or more) of varicella vaccine received at any age and without a history of varicella disease.
h Includes 1 dose (or more) of tetanus toxoid-diphtheria vaccine (Td) or tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since age 10.
i Includes 1 dose (or more) of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since age 10.
j Includes 1 dose (or more) of meningococcal conjugate vaccine (MenACWY) and meningococcal-unknown type vaccine.
k Includes 1 dose (or more) quadrivalent or bivalent human papillomavirus vaccine (HPV). Percentages reported among females only.
l Includes 3 doses (or more) quadrivalent or bivalent human papillomavirus vaccine (HPV). Percentages reported among females only.
NOTE: Data include routinely recommended vaccines (Tdap, MenACWY, HPV—females only) and early childhood vaccines (MMR, HepB, Var) for catch-up coverage estimates.
SOURCE: Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases and National Center for Health Statistics, National Immunization Survey—Teen.